Linked here is a detailed quantitative analysis of Abbvie Inc. (ABBV). Below are some highlights from the above linked analysis:
Company Description: Abbvie Inc. is a global research-based pharmaceuticals business that emerged as a separate entity following its spin-off from Abbott Laboratories at the start of 2013. AbbVie's key drug is Humira for rheumatoid arthritis.
Read More...
Dividend Growth Stocks News
- 3 Dividend Stocks Offering Yields From 3% To 4.9% - Yahoo Finance - 7/24/2025
- 3 Dividend Stocks to Double Up on Right Now - The Motley Fool - 7/24/2025
- 3 Dividend Stocks Beating the S&P in 2025 - MSN - 7/24/2025
- I Am Buying 5 Blue-Chip Dividend Stocks That Have Been Crushed in 2025 - 24/7 Wall St. - 7/24/2025
- 3 Top Dividend Stocks to Maximize Your Retirement Income - Yahoo Finance - 7/24/2025
- Chevron Corporation (CVX) Dividend Stock Analysis - 7/18/2025
- Emerson Electric Co. (EMR) Dividend Stock Analysis - 7/11/2025
- Amgen, Inc. (AMGN) Dividend Stock Analysis - 6/27/2025
- W.W. Grainger, Inc. (GWW) Dividend Stock Analysis - 6/20/2025
- Abbvie Inc. (ABBV) Dividend Stock Analysis - 6/13/2025
Abbvie Inc. (ABBV) Trading At A Deep Discount, But With Risks
Posted by D4L | Thursday, November 06, 2014 | ArticleLinks | 0 comments »________________________________________________________________
Subscribe to:
Post Comments (Atom)
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.